Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Teva gets more than half of U.S. Copaxone patients converted to long-lasting version
Teva gets more than half of U.S. Copaxone patients converted to long-lasting version
Teva gets more than half of U.S. Copaxone patients converted to long-lasting version
Submitted by
admin
on August 1, 2014 - 6:16pm
Source:
Fierce Pharma
News Tags:
Teva Pharmaceutical
MS
multiple sclerosis
Copaxone
Headline:
Teva gets more than half of U.S. Copaxone patients converted to long-lasting version
Do Not Allow Advertisers to Use My Personal information
